These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 10937952)

  • 41. Hemodynamic and neurohumoral effects of the angiotensin II antagonist losartan in patients with heart failure.
    Dickstein K; Gottlieb S; Fleck E; Kostis J; Levine B; DeKock M; LeJemtel T
    J Hypertens Suppl; 1994 Jul; 12(2):S31-5. PubMed ID: 7965263
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Angiotensin converting enzyme inhibition, AT1 receptor inhibition, and combination therapy with pacing induced heart failure: effects on left ventricular performance and regional blood flow patterns.
    Krombach RS; Clair MJ; Hendrick JW; Houck WV; Zellner JL; Kribbs SB; Whitebread S; Mukherjee R; de Gasparo M; Spinale FG
    Cardiovasc Res; 1998 Jun; 38(3):631-45. PubMed ID: 9747431
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of baseline data, initial course, and management: losartan versus captopril following acute myocardial infarction (The OPTIMAAL Trial). OPTIMAAL Trial Steering Committee and Investigators. Optimal Trial in Myocardial Infarction with the Angiotensin II Antagonist Losartan.
    Dickstein K; Kjekshus J;
    Am J Cardiol; 2001 Mar; 87(6):766-71, A7. PubMed ID: 11249900
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of acetylsalicylic acid on peripheral hemodynamics in patients with chronic heart failure treated with angiotensin-converting enzyme inhibitors.
    van Wijngaarden J; Smit AJ; de Graeff PA; van Gilst WH; van der Broek SA; van Veldhuisen DJ; Lie KI; Wesseling H
    J Cardiovasc Pharmacol; 1994 Feb; 23(2):240-5. PubMed ID: 7511753
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Losartan versus captopril in elderly patients with heart failure.
    Sechi LA; Catena C; Bartoli E
    Lancet; 1997 May; 349(9063):1474; author reply 1475. PubMed ID: 9164337
    [No Abstract]   [Full Text] [Related]  

  • 46. Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial. Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist Losartan.
    Dickstein K; Kjekshus J;
    Lancet; 2002 Sep; 360(9335):752-60. PubMed ID: 12241832
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of losartan and captopril on QT dispersion in elderly patients with heart failure. ELITE study group.
    Brooksby P; Robinson PJ; Segal R; Klinger G; Pitt B; Cowley AJ
    Lancet; 1999 Jul; 354(9176):395-6. PubMed ID: 10437875
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neurohormonal reactivation in heart failure patients on chronic ACE inhibitor therapy: a longitudinal study.
    Lee AF; MacFadyen RJ; Struthers AD
    Eur J Heart Fail; 1999 Dec; 1(4):401-6. PubMed ID: 10937954
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Addition of angiotensin II receptor blockade to maximal angiotensin-converting enzyme inhibition improves exercise capacity in patients with severe congestive heart failure.
    Hamroff G; Katz SD; Mancini D; Blaufarb I; Bijou R; Patel R; Jondeau G; Olivari MT; Thomas S; Le Jemtel TH
    Circulation; 1999 Mar; 99(8):990-2. PubMed ID: 10051289
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Safety, tolerability, and neurohormonal changes of the combination captopril plus losartan in the early postinfarction period: a pilot study.
    Di Pasquale P; Bucca V; Scalzo S; Paterna S
    Cardiovasc Drugs Ther; 1998 May; 12(2):211-6. PubMed ID: 9652880
    [TBL] [Abstract][Full Text] [Related]  

  • 51. New competition in the realm of renin-angiotensin axis inhibition; the angiotensin II receptor antagonists in congestive heart failure.
    Martineau P; Goulet J
    Ann Pharmacother; 2001 Jan; 35(1):71-84. PubMed ID: 11197588
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Temporal differences between the involvement of angiotensin II and endothelin in the cardiovascular responses to endotoxaemia in conscious rats.
    Gardiner SM; Kemp PA; March JE; Bennett T
    Br J Pharmacol; 1996 Dec; 119(8):1619-27. PubMed ID: 8982510
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Differences in first dose response to angiotensin converting enzyme inhibition in congestive heart failure: a placebo controlled study.
    MacFadyen RJ; Lees KR; Reid JL
    Br Heart J; 1991 Sep; 66(3):206-11. PubMed ID: 1657084
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Haemodynamic and neurohumoral response to exercise in patients with congestive heart failure treated with captopril.
    Creager MA; Faxon DP; Weiner DA; Ryan TJ
    Br Heart J; 1985 Apr; 53(4):431-5. PubMed ID: 3885981
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Combined angiotensin-converting enzyme inhibition and adrenomedullin in an ovine model of heart failure.
    Rademaker MT; Charles CJ; Cooper GJ; Coy DH; Espiner EA; Lewis LK; Nicholls MG; Richards AM
    Clin Sci (Lond); 2002 Jun; 102(6):653-60. PubMed ID: 12049620
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The cost-effectiveness of losartan versus captopril in patients with symptomatic heart failure.
    Dasbach EJ; Rich MW; Segal R; Gerth WC; Carides GW; Cook JR; Murray JF; Snavely DB; Pitt B
    Cardiology; 1999; 91(3):189-94. PubMed ID: 10516413
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Effect of cilazapril on exercise tolerance and neurohumoral factors in patients with asymptomatic chronic heart failure after myocardial infarction].
    Fujiwara M; Asakuma S; Nakamura T; Nakamura K; Iwasaki T
    J Cardiol; 1995 Nov; 26(5):287-92. PubMed ID: 8523261
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Peripheral haemodynamic effects of inhibition of prostaglandin synthesis in congestive heart failure and interactions with captopril.
    Townend JN; Doran J; Lote CJ; Davies MK
    Br Heart J; 1995 May; 73(5):434-41. PubMed ID: 7786658
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical and neurohormonal effects of nicardipine hydrochloride in patients with severe chronic heart failure receiving angiotensin-converting enzyme inhibitor therapy.
    Benatar D; Hall V; Reddy S; Gheorghiade M
    Am J Ther; 1998 Jan; 5(1):25-32. PubMed ID: 10099034
    [TBL] [Abstract][Full Text] [Related]  

  • 60. ACE inhibitors or AT-1 antagonists - which is OPTIMAAL after acute myocardial infarction?
    Doggrell SA
    Expert Opin Pharmacother; 2003 Mar; 4(3):407-9. PubMed ID: 12614193
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.